Emids Achieves Anthropic Select Services Partner Status to Scale AI Across Healthcare

Partnership pairs Claude with Emids' decades of healthcare context to accelerate AI adoption and deliver measurable AI ROI across payer, provider and health tech workflows

Nashville, TN, [Monday, 5 October, 2026] - Emids, an AI-led engineering and platform services company for the healthcare and life sciences industry, today announced that it has achieved Select Services Partner status in Anthropic's Claude Partner Network. The designation recognizes Emids' certified practitioners and customer deployments with Claude as the company expands its use across healthcare software engineering, operations, and agentic workflows.

Healthcare organizations are ready to put frontier AI to work, but adoption at scale depends on context: the payer rules, clinical codes, member data and regulatory requirements that shape every decision. Emids brings 36 years of healthcare experience to this deployment layer, combining its industry context with Claude's capabilities to help healthcare organizations put AI to work in complex, regulated environments.

That context comes to life through Pacca AI, Emids' agentic healthcare platform, that connects Claude's capabilities to the healthcare data and enterprise systems required for production deployment. Its healthcare ontologies provide context across codes, policies, members and workflows, while a common control plane provides orchestration, governance, model choice and auditability.

Emids' Forward-Deployed Context Engineers (FDCEs) work alongside customer teams to translate healthcare knowledge, data and operational exceptions into software and AI agents that can be deployed and scaled within their environments.

Claude is changing the economics of what can be built and how quickly. In healthcare, the compelling opportunity is to build products with context and reliability while leveraging the new unit economics. Here is where Emids comes in. We bring decades of healthcare context across the policies, workflows, data and operating realities that turn Claude's intelligence into something healthcare organizations can put to work reliably in production.

The partnership is already delivering measurable results. At a national healthcare network, nearly 30 Emids engineers use Claude Code to develop prior authorization and other critical systems, contributing to a 25-30% faster release cadence and 40-50% reduction in test-authoring effort.

For a HealthTech company, Emids also uses Claude within Pacca AI to process claims appeals. Claude helps interpret documents and prepare appeal content, while payer rules, automation and human review govern the process. The complete workflow cut processing time by 95%, from as much as four hours per appeal to about ten minutes.

Emids plans to build on its Select status by expanding its Claude practice across payer, provider and health tech workflows, including AI-native product engineering.

About Emids

Headquartered in Nashville, Emids was born in healthcare, built for healthcare, and is focused on moving healthcare forward. For 36 years, Emids has helped payers, providers, biopharma, medtech, and health tech companies move beyond digital transformation into intelligent transformation, modernizing the systems healthcare runs on and scaling AI into the workflows where outcomes are won or lost. With healthcare-trained ontologies, Pacca AI Control Plane, AI-led engineering, modern data and platform services, and embedded Forward-Deployed Context Engineers, Emids delivers its AI-led Context Engineering model with the speed of technology, the precision of healthcare, and the accountability of a true operating partner.